Michael Lane
At a glance: Michael Lane is President at Idexx Laboratories (IDXX). Their latest SEC Form 4, filed Nov 5, 2026, reported a sale of $167K. On file: 0 purchase lines ($0) and 3 sale lines ($2.7M).
Disclosed holdings: about $2.9M of IDXX stock: 4,076 shares reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 13, 2026 close of $704.23. This counts only IDXX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
President at Idexx Laboratories Inc /De (IDXX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 2437,812 held (−3%) | $687.85 | $167K | +2.4% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,0595,753 held (−26%) | $689.70 | $1.4M | +2.1% |
| Nov 5SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,6774,076 held (−29%) | $687.46 | $1.2M | +2.4% |
- Sell
President Michael Lane sold $1.4M of IDXX at $689.70 — cuts the stake by 26%.
- Sell
President Michael Lane sold $1.2M of IDXX at $687.46 — cuts the stake by 29%.
Follow Michael Lane
Get one email when Michael Lane files a new purchase or sale. Free.
At most one email a day about Michael Lane, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.